BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
ACTON, Mass., May 08, 2018 -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair analysis drug testing, today announced that James Abely has been promoted to the position of Vice President and General Counsel.
In this important role, Jim is responsible for directing and managing all of the company's legal activities, including working closely with the company's clients, and reports directly to the company's CEO. Jim joined Psychemedics in June 2016 as Associate General Counsel, after practicing law for 6 years with the Boston firm of Goodwin Procter LLP, following his graduation from the University of Virginia School of Law. Jim was later promoted to General Counsel.
In making the announcement, Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated "Jim has been an outstanding addition to our team at Psychemedics. In heading up this important area in our company for the past two years, Jim has worked diligently in numerous legal matters and has clearly demonstrated his ability and strong work ethic. He has won the complete confidence of the other members of our management team, as well as our clients. Besides providing our clients with the most vigorous drug test available and outstanding client service, we also extensively support our clients on any legal challenge. We not only provide a litigation packet and expert testimony, but also legal assistance for our clients' legal team to come up to speed quickly. That's why this is such an important role in our company."
Contact:
Raymond C. Kubacki
Chairman, President & CEO
(978) 206-8220
[email protected]
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.
The Psychemedics web site is www.psychemedics.com
